Location History:
- Cologne, DE (2017)
- Köln, DE (2020)
Company Filing History:
Years Active: 2017-2020
Title: Innovative Contributions of Inventor Stefan Tomiuk
Introduction
Stefan Tomiuk is a distinguished inventor based in Köln, Germany. With a remarkable portfolio of two patents, his work focuses on advancements in cancer therapy and immunology. His innovative contributions showcase a deep commitment to developing effective treatments for patients.
Latest Patents
Tomiuk's latest patents include groundbreaking inventions aimed at improving cancer therapies. The first patent, titled "Chimeric Antigen Receptor Specific for Tumor Cells," details a chimeric antigen receptor (CAR) that is designed to target various tumor-associated antigens. This invention encompasses cell populations expressing such CARs, which can be utilized in innovative cancer treatment options.
His second patent, "Humanized Antibody or Fragment Thereof Specific for CD45R0," features a humanized antibody that specifically targets the CD45R0 antigen. This patent explains the structure of the antibody, including humanized heavy and light chain variable domains. Additionally, it emphasizes the potential applications of this technology in enriching or depleting CD45R0-expressing cells, which has significant implications for therapeutic methodologies.
Career Highlights
Stefan Tomiuk has made substantial contributions to the field of biotechnology through his work at Miltenyi Biotech GmbH and Miltenyi Biotec, GmbH. His career reflects a dedication to researching and developing innovative solutions in life sciences. His impactful inventions continue to influence the development of effective therapeutic strategies against cancer.
Collaborations
Throughout his professional journey, Tomiuk has collaborated with notable peers in the field. His coworkers, Dominik Eckardt and Andreas Bosio, have been instrumental in driving forward the innovative projects that define his career. Their collaborative efforts highlight the importance of teamwork in advancing scientific discovery.
Conclusion
Stefan Tomiuk exemplifies the spirit of innovation within the biotechnology field. His patents represent significant advancements in cancer therapies and immunology, contributing to the ongoing pursuit of effective treatments. The collaborative environment in which he operates further enhances the potential for groundbreaking discoveries and improvements in medical science.